| 1 |
34735897 | A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer. | 2022 Jan |
1 |
| 2 |
32514232 | Virtual docking screening and QSAR studies to explore AKT and mTOR inhibitors acting on PI3K in cancers. | 2020 |
1 |
| 3 |
33659212 | Pictilisib Enhances the Antitumor Effect of Doxorubicin and Prevents Tumor-Mediated Bone Destruction by Blockade of PI3K/AKT Pathway. | 2020 |
2 |
| 4 |
31553879 | Preclinical Evaluation of a Fluorine-18 (18F)-Labeled Phosphatidylinositol 3-Kinase Inhibitor for Breast Cancer Imaging. | 2019 Nov 4 |
1 |
| 5 |
28029662 | Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing. | 2017 Jan 17 |
3 |
| 6 |
28291364 | Multifunctional Nanoparticles Loading with Docetaxel and GDC0941 for Reversing Multidrug Resistance Mediated by PI3K/Akt Signal Pathway. | 2017 Apr 3 |
1 |
| 7 |
28536078 | AKT is critically involved in the antagonism of BRAF inhibitor sorafenib against dabrafenib in colorectal cancer cells harboring both wild-type and mutant (V600E) BRAF genes. | 2017 Jul 15 |
1 |
| 8 |
27465249 | PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma. | 2016 Jul 28 |
1 |
| 9 |
25370471 | First-in-human phase I study of pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors. | 2015 Jan 1 |
1 |
| 10 |
25941816 | Ellagic Acid Enhances the Efficacy of PI3K Inhibitor GDC-0941 in Breast Cancer Cells. | 2015 |
1 |
| 11 |
24601221 | More antitumor efficacy of the PI3K inhibitor GDC-0941 in breast cancer with PIK3CA mutation or HER2 amplification status in vitro. | 2014 Jan |
1 |
| 12 |
23602735 | Synergistic inhibition of thyroid cancer by suppressing MAPK/PI3K/AKT pathways. | 2013 Oct |
2 |
| 13 |
23711387 | Downregulation of Erbin in Her2-overexpressing breast cancer cells promotes cell migration and induces trastuzumab resistance. | 2013 Nov |
2 |
| 14 |
23006739 | The antitumor effect of GDC-0941 alone and in combination with rapamycin in breast cancer cells. | 2012 |
2 |
| 15 |
21994956 | GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathways. | 2011 Dec |
1 |
| 16 |
20361045 | Physical association of PDK1 with AKT1 is sufficient for pathway activation independent of membrane localization and phosphatidylinositol 3 kinase. | 2010 Mar 26 |
2 |
| 17 |
20826841 | Nuclear phospho-Akt increase predicts synergy of PI3K inhibition and doxorubicin in breast and ovarian cancer. | 2010 Sep 8 |
1 |
| 18 |
19382889 | High-throughput screening compatible cell-based assay for interrogating activated notch signaling. | 2009 Feb |
1 |